Date:2/13/2013

0;Earnings Per Share) adjust for certain specified items. All Non-GAAP financial measures are intended to supplement the applicable GAAP measures and should not be considered in isolation from, or a replacement for, financial measures prepared in accordance with GAAP. Refer to Hospira's Form 8-K furnished on February 13, 2013.Hospira, Inc.Condensed Consolidated Balance Sheets(Unaudited)(dollars in millions)December 31,December 31,20122011AssetsCurrent Assets:Cash and cash equivalents$
772.1$
597.5Trade receivables, less allowances of $12.7 in 2012 and $15.7 in 2011646.9639.9Inventories, net997.81,027.0Deferred income taxes214.4174.4Prepaid expenses53.945.9Other receivables75.386.0Total Current Assets2,760.42,570.7Property and equipment, net1,445.11,355.0Intangible assets, net266.8355.8Goodwill1,079.11,082.9Deferred income taxes296.8232.2Investments71.848.7Other assets168.6133.8Total Assets$
,088.6$
5,779.1Liabilities and Shareholders' EquityCurrent Liabilities:Short-term borrowings$
28.9$
36.6Trade accounts payable276.0241.3Salaries, wages and commissions144.0113.0Other accrued liabilities580.3456.9Total Current Liabilities1,029.2847.8Long-term debt1,706.81,711.9Deferred income taxes4.45.7Post-retirement obligations and other long-term liabilities306.5275.7Commitments and ContingenciesTotal Shareholders' Equity3,041.72,938.0Total Liabilities and Shareholders' Equity$
,088.6$
5,779.1Hospira, Inc.Condensed Consolidated Statements of Cash Flows(Unaudited)(dollars in millions)Years Ended December 31,Cash Flow From Operating Activities:20122011Net income (loss)$
44.2$
(9.4)Adjustments to reconcile net income (loss) to net cash from operating activities-Depreciation164.0164.6Amortization of intangible assets83.691.5Stock-based compensation expense40.041.2Undistributed equity income from affili
'/>"/>

SOURCE Hospira, Inc. Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Related medicine technology :

1. Hospira to Present at Upcoming Investor Conferences
2. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
3. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
4. Hospira Reports Third-Quarter 2012 Results
5. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
6. Hospira Reports Second-Quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira to Host Conference Call for Second-quarter 2012 Results
9. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
10. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
11. Hospira to Present at Upcoming Investor Conferences